650 Stock Overview
Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Renhe Pharmacy Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.53 |
| 52 Week High | CN¥7.59 |
| 52 Week Low | CN¥5.09 |
| Beta | 0.40 |
| 1 Month Change | -0.76% |
| 3 Month Change | 19.60% |
| 1 Year Change | -2.39% |
| 3 Year Change | -18.17% |
| 5 Year Change | -28.71% |
| Change since IPO | 1,140.01% |
Recent News & Updates
Shareholder Returns
| 650 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.3% | 2.7% | 1.2% |
| 1Y | -2.4% | -10.9% | -12.6% |
Return vs Industry: 000650 exceeded the CN Pharmaceuticals industry which returned -12.8% over the past year.
Return vs Market: 000650 exceeded the CN Market which returned -13.2% over the past year.
Price Volatility
| 650 volatility | |
|---|---|
| 650 Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in CN Market | 12.5% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 000650 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000650's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 6,062 | n/a | www.renheyaoye.com |
Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.
Renhe Pharmacy Co., Ltd. Fundamentals Summary
| 650 fundamental statistics | |
|---|---|
| Market cap | CN¥9.14b |
| Earnings (TTM) | CN¥562.25m |
| Revenue (TTM) | CN¥4.91b |
16.3x
P/E Ratio1.9x
P/S RatioIs 650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 650 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.91b |
| Cost of Revenue | CN¥3.13b |
| Gross Profit | CN¥1.79b |
| Other Expenses | CN¥1.23b |
| Earnings | CN¥562.25m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.40 |
| Gross Margin | 36.38% |
| Net Profit Margin | 11.44% |
| Debt/Equity Ratio | 0.06% |
How did 650 perform over the long term?
See historical performance and comparison